Home › Research › Biomarkers
Sex differences in Alzheimer's disease plasma biomarker levels and clinical utility
Marta Milà‐Alomà, Isabella Hausle, Alison Myoraku, Clara Sorensen, Pamela Thropp, Leslie M. Shaw, Michael Walter Weiner, Duygu Tosun et al.. Alzheimer s & Dementia, 2026-02-01
Topic: Amyloid, tau and blood-test diagnosis
Plain-language summary
Among CU participants, men had lower Aβ42 and GFAP, and higher p-tau217/Aβ42. Among the CI group, GFAP, p-tau217 and p-tau217/Aβ42 were higher in women. Overall classification performance was similar across sexes; however, p-tau217 and p-tau217/Aβ42 showed higher specificity and positive predictive value in CU women, with the opposite pattern observed in CI participants. In CU participants, p-tau217 and p-tau217/Aβ42 predicted modified Preclinical Alzheimer Cognitive Composite decline only in women. Sex-specific plasma biomarker cutoffs may not be necessary. However, sex influences biomarker levels, classification metrics, and prognostic value, highlighting the importance of considering sex differences when interpreting biomarker results and optimizing trial enrichment strategies.
What this study adds
Evidence grade: Low
Sex influenced plasma biomarker levels, classification metrics and prognostic value, though overall classification performance was similar across sexes. This is about interpreting biomarkers and enriching trials, not about treating or preventing Alzheimer's disease.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Milà‐Alomà, M., Hausle, I., Myoraku, A., Sorensen, C., Thropp, P., Shaw, L. M., et al. (2026). Sex differences in Alzheimer's disease plasma biomarker levels and clinical utility. Alzheimer s & Dementia. https://doi.org/10.1002/alz.71244
Vancouver
Milà‐Alomà M, Hausle I, Myoraku A, Sorensen C, Thropp P, Shaw LM, et al. Sex differences in Alzheimer's disease plasma biomarker levels and clinical utility. Alzheimer s & Dementia. 2026. doi:10.1002/alz.71244. PMID: 41755682.
BibTeX
@article{milaaloma2026-41755682,
author = {Milà‐Alomà, Marta and Hausle, Isabella and Myoraku, Alison and Sorensen, Clara and Thropp, Pamela and Shaw, Leslie M. and Weiner, Michael Walter and Tosun, Duygu and others},
title = {{Sex differences in Alzheimer's disease plasma biomarker levels and clinical utility}},
journal = {Alzheimer s \& Dementia},
year = {2026},
doi = {10.1002/alz.71244},
pmid = {41755682},
url = {https://doi.org/10.1002/alz.71244}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record's author list ends in “et al.”, so not every author is named. Check the citation against the original before you use it.
Key findings
- Among CU participants, men had lower Aβ42 and GFAP, and higher p-tau217/Aβ42.
- Among the CI group, GFAP, p-tau217 and p-tau217/Aβ42 were higher in women.
- Overall classification performance was similar across sexes; however, p-tau217 and p-tau217/Aβ42 showed higher specificity and positive predictive value in CU women, with the opposite pattern observed in CI participants.
- In CU participants, p-tau217 and p-tau217/Aβ42 predicted modified Preclinical Alzheimer Cognitive Composite decline only in women.
- Sex-specific plasma biomarker cutoffs may not be necessary.
Why it matters
Sex influenced plasma biomarker levels, classification metrics and prognostic value, though overall classification performance was similar across sexes. This is about interpreting biomarkers and enriching trials, not about treating or preventing Alzheimer's disease.
New to this subject? Start with our plain-English guide: Blood tests & biomarkers →
Study details
- Evidence strengthLow
How this study scored 41/100
Published in a peer-reviewed journal. Scored zero for study design, sample size, effect reported, studied in people and randomized / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Alzheimer s & Dementia) |
| Journal's citation record | 2 / 4 | Alzheimer s & Dementia: journal h-index 228 (OpenAlex, 2026-10-29) |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 5 / 5 | 2026 — within 1 year(s) of the newest study here |
| Sample size | 0 / 4 | Participant count not stated — scores zero (not stated in the record — scored 0) |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 0 / 3 | Not stated whether this was studied in people — scores zero (not stated in the record — scored 0) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 1 / 7 | Cited 2 times (OpenAlex, 2026-10-10) |
| Citations per year | 1 / 5 | 1.0 citations a year over 2 year(s) since 2026 |
| Impact for its field and year | 4 / 6 | Cited 9.4× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 1 / 6 | Cited by 1 other studies in this library |
| Still being cited | 0 / 4 | Cited 2 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 1 / 4 | Last-listed author for the Alzheimer’s Disease Neuroimaging Initiative: h-index 12 (OpenAlex, whole career) |
| Institution's track record | 2 / 3 | University of California, Berkeley: institution h-index 2,012 (OpenAlex) |
| Multicenter collaboration | 2 / 3 | OpenAlex lists 5 institution(s) in 1 country |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 41755682) |
| Free to read | 2 / 2 | Free to read |
| Total | 41 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Related
Studies in the library that share something with this one. The line above each title says what.
Later studies that cite this one
1 study in the alzhub library lists this one in its references.
Related studies in Biomarkers from nearby years
Also tagged “cerebrospinal”
820 studies in the library carry the topic tag “cerebrospinal”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 820 tagged studies.